No Data
No Data
GH Research PLC Attends Key Neuropsychopharmacology Conference
Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $18
Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect?
GH Research Q3 2024 Results and Clinical Updates
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
Promising Advancements in GH Research's Clinical Trials Boost Buy Rating
No Data